Cardiopulmonary risk resource available
By Kathy McCarthy
Cardiopulmonary risk is the risk of serious respiratory or cardiovascular events in patients with chronic obstructive pulmonary disease. These include, but are not limited to, COPD exacerbations, myocardial infarction, stroke, heart failure decompensation, arrhythmia, and death due to any of these events.
AstraZeneca, one of TAFP’s proud Partners in Health, released an infographic to be used as a resource on the topic.
TAFP’s Partners in Health program connects family physicians with organizations committed to supporting family medicine and promoting the health of all Texans. Our Partners provide patient education and high-value tools designed to help family physicians and their care teams deliver well-coordinated, comprehensive primary care. Go to Partners in Health to learn more.